Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review
- PMID: 12496040
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review
Abstract
Endometrial cancer is a disease of the affluent, developed world, where epidemiological studies have shown that > or =40% of its incidence can be attributed to excess body weight. An additional proportion may be because of lack of physical activity. Alterations in endogenous hormone metabolism may provide the main links between endometrial cancer risk, and excess body weight and physical inactivity. Epidemiological studies have shown increased endometrial cancer risks among pre- and postmenopausal women who have elevated plasma androstenedione and testosterone, and among postmenopausal women who have increased levels of estrone and estradiol. Furthermore, there is evidence that chronic hyperinsulinemia is a risk factor. These relationships can all be interpreted in the light of the "unopposed estrogen" hypothesis, which proposes that endometrial cancer may develop as a result of the mitogenic effects of estrogens, when these are insufficiently counterbalanced by progesterone. In our overall synthesis, we conclude that development of ovarian hyperandrogenism may be a central mechanism relating nutritional lifestyle factors to endometrial cancer risk. In premenopausal women, ovarian hyperandrogenism likely increases risk by inducing chronic anovulation and progesterone deficiency. After the menopause, when progesterone synthesis has ceased altogether, excess weight may continue increasing risk through elevated plasma levels of androgen precursors, increasing estrogen levels through the aromatization of the androgens in adipose tissue. The ovarian androgen excess may be because of an interaction between obesity-related, chronic hyperinsulinemia with genetic factors predisposing to the development of ovarian hyperandrogenism.
Similar articles
-
Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).J Natl Cancer Inst. 2005 May 18;97(10):755-65. doi: 10.1093/jnci/dji132. J Natl Cancer Inst. 2005. PMID: 15900045
-
Progestogen deficiency and endometrial cancer risk.Maturitas. 2009 Apr 20;62(4):334-7. doi: 10.1016/j.maturitas.2008.12.018. Epub 2009 Feb 23. Maturitas. 2009. PMID: 19231117 Review.
-
Energy balance, physical activity, and cancer risk.Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Methods Mol Biol. 2009. PMID: 19107429 Review.
-
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15. doi: 10.1093/jnci/djj376. J Natl Cancer Inst. 2006. PMID: 17018787
-
Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):723-30. doi: 10.1158/1055-9965.EPI-06-0675. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17416763
Cited by
-
Ovarian volume assessment in relation to histologic findings and sex hormone levels in women with postmenopausal bleeding and thickened endometrium.Ann Saudi Med. 2012 Nov-Dec;32(6):588-92. doi: 10.5144/0256-4947.2012.588. Ann Saudi Med. 2012. PMID: 23396021 Free PMC article.
-
Management of endometrial precancers.Obstet Gynecol. 2012 Nov;120(5):1160-75. doi: 10.1097/aog.0b013e31826bb121. Obstet Gynecol. 2012. PMID: 23090535 Free PMC article. Review.
-
Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study.J Clin Endocrinol Metab. 2012 Sep;97(9):3216-23. doi: 10.1210/jc.2012-1490. Epub 2012 Jun 22. J Clin Endocrinol Metab. 2012. PMID: 22730518 Free PMC article.
-
The Role of Endometrial Sampling before Hysterectomy in Premenopausal Women with Abnormal Uterine Bleeding.J Clin Med. 2024 Jun 25;13(13):3709. doi: 10.3390/jcm13133709. J Clin Med. 2024. PMID: 38999275 Free PMC article.
-
Perspective: the evolution of hormones and person perception-a quantitative genetic framework.Front Psychol. 2024 Jun 17;15:1395974. doi: 10.3389/fpsyg.2024.1395974. eCollection 2024. Front Psychol. 2024. PMID: 38952835 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical